Levamisole therapy in children at risk from severe measles

References

• Study Group for Bronchogenic Carcinoma. Immunopotentiation with Levamisole in respectable bronchogenic carcinoma: a double blind controlled trial. Br Med J 1975; 3: 4614.
   Google Scholar
• Rojos AF, Miciewicz E, Feierrstein JN, Glait H, Olivan AJ. Levamisole in advanced breast cancer. Lancet 1976; 1: 211–215.
   PubMed Web of Science ®Google Scholar
• Wilkins SA, Olkowski Z. Immunocompetence of cancer patients treated with Levamisole. Cancer 1977; 38: 487–493.
   Web of Science ®Google Scholar
• Symoens J, Brugmans J. Treatment of recurrent aphthous stomatitis and herpes with Levamisole. Br Med J 1974; 4: 592.
   PubMed Web of Science ®Google Scholar
• Royal Society of Medicine. Levamisole in Infectious Diseases; proceedings of a Panel Discussion held at the Royal Society of Medicine, London on 14th March, 1978. In: Forum on Immunotherapy 1979; 2 (2): 3–20.
   Google Scholar
• Dils F. A placebo controlled, double-blind evaluation of Levamisole in the reduction of the frequency, duration and severity of attacks in children suffering from recurrent upper respiratory tract infections. J Int Med Res 1979; 7: 302–4.
   PubMed Web of Science ®Google Scholar
• De Loore F, Heek E, Van Eygen M, Casneuf J. Levamisole (Ri2564) in the prevention of recurrent upper respiratory tract infection in children: a double blind placebo-controlled study. Curr Med Res Opin 1979; 6: 142–7.
   PubMed Web of Science ®Google Scholar
• Van Eygen M, Dils F, Gillerot J, Verscheuren E. A double-blind pediatric evaluation of Levamisole in the prevention of recurrent upper respiratory tract infections. Eur J Pediatr 1979; 131: 147–53.
   PubMed Web of Science ®Google Scholar
• El-Ghobarey AF, Mavrikakis ME, McCleod M, Reynolds PMG, Capell HA, Spencer DG, Balint G, Mathieu JP, McAllister T, Cooney A, Dick WC. Clinical and laboratory studies in Levamisole in patients with rheumatoid arthritis. Quart J Med New Series XLVII 1978; 47: 385–400.
   PubMed Web of Science ®Google Scholar
• Multicentre Study Group. Levamisole in rheumatoid arthritis. A randomised double-blind study comparing two disage regimens of Levamisole with placebo. Lancet 1978; 2: 1007–12.
   Google Scholar
• Levy J. Correlations of clinical and laboratory effects of treatment with Levasimole in autoimmune disease. Cancer Treat Rep 1978; 62: 1715–19.
   PubMedGoogle Scholar
• Lancet. Levasimole—a cautionary note. Leader 1979; 2: 291–2.
   PubMed Web of Science ®Google Scholar
• Kelly MT. Modulation of macrophage function by Levamisole. J Reticuloendothel Soc 1978; 24: 139–45.
   Google Scholar
• Hadden JW, Englard A, Sadlik JR, Hadden EM. The comparative effects of Isoprinosine, Levamisole, Mercuryl Dipeptide and SM 1213 on lymphocyte and macrophage proliferation and activation in vitro. Int J Immunopharm 1978; 1: 17–27.
   Web of Science ®Google Scholar
• Lomnitzer R, Rabson AR. The effect of Levamisole on E. rosette formation by trypsinized lymphocytes. Clin Exp Immunol 1978; 33: 499–502.
   PubMed Web of Science ®Google Scholar
• de Cock W, de Cree J, Verhaegen H. Restoration by Levamisole of rosette-forming cells inhibited by histamine. J Immunopharmacol 1978–9; 1: 115–22.
   PubMedGoogle Scholar
• Anderson R, Glover A, Koornhoff HJ, Rabson AR. In vitro stimulation of neutrophil motility by Levasimole; maintenance of cGMP levels in chemotactically stimulated Levasimoletreated neutrophils. J Immunol 1976; 117: 428–32.
   PubMed Web of Science ®Google Scholar
• Anderson R, Oosthuizen R, Theron A, van Rensburg AJ. The in vitro evaluation of certain neutrophil and lymphocyte functions following the ingestion of 150 mg oral dose of Levamisole: assessment of the extent and duration of stimulation of neutrophil Chemotaxis, protein iodination and lymphocyte transformation. Clin Exp Immunol 1979; 35: 478–83.
   PubMed Web of Science ®Google Scholar
• Renoux G, Renoux M, Teller MN, McMahon S, Guillaumin JM. Potentiation of T-cell mediated immunity by Levamisole. Clin Exp Immunol 1976; 25: 288–96.
   PubMed Web of Science ®Google Scholar
• Lancet. Measles in adults. Leader 1979; 2: 834–5.
   PubMed Web of Science ®Google Scholar
• Smith H. Measles again. Br Med J 1980; 280: 766–7.
   PubMed Web of Science ®Google Scholar
• Morley D. Severe measles in the tropics. I. Br Med J 1969; 1: 297–300.
   PubMed Web of Science ®Google Scholar
• Dossetor J, Whittle HC, Greenwood BM. Persistent measles infection in malnourished children. Br Med J 1977; 1: 1633–5.
   PubMed Web of Science ®Google Scholar
• Coovadia HM, Wesley A, Brain P. Immunological events in acute measles influencing outcome. Arch Dis Childh 1978; 53: 861–7.
   PubMed Web of Science ®Google Scholar
• Boyun A. Isolation of leucocytes from human blood. Scan J Clin Lab Invest 1968; 21: 9–29.
   Web of Science ®Google Scholar
• Brain P, Cox J, Duursma J, Pudifin D. T and B lymphocytes in three population groups. Clin Exp Immunol 1976; 23: 248–51.
   Web of Science ®Google Scholar
• Cutchins EC. A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles. J Immunol 1962; 88: 788–95.
   PubMed Web of Science ®Google Scholar
• Park BH, Good RA. A new micromethod for evaluating lymphocyte responses to phytohaemagglutinin: quantitative analysis of the function of thymus-dependent cells. Proc Nat Acad Sci 1972; 69: 371–3.
   PubMed Web of Science ®Google Scholar
• Clausen JE. Tuberculin induced migration inhibition of human periferal leucocytes in agarose medium. Acta Allergol 1971; 26: 56–80.
   PubMedGoogle Scholar
• Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by a single radial immunodiffusion. Int J Immunochem 1965; 2: 235–54.
   PubMedGoogle Scholar
• Lachmann PJ, Hobart MJ, Aston WP. In: Weir DM. ed. Handbook of Experimental Immunology. Blackwell Scientific Publications, Oxford, 1973 Chapter 5; 5–10.
   Google Scholar
• Becroft DMO. Histopathology of fatal adenovirus infection of the respiratory tract in young children. J Clin Path 1967; 20: 561–9.
   PubMed Web of Science ®Google Scholar
• Nahmias AJ, Griffith G, Snitzer J. Fatal pneumonia associated with Adenovirus Type 7. Amer J Dis Childh 1967; 114: 36–41.
   PubMedGoogle Scholar
• Black FL. In: Rose NR, Friedman H. (eds) Manual of Clinical Immunology. American Society for Microbiology. 1976; 445.
   Google Scholar
• Whittle HC, Smith JS, Kogbe OI, Dossetor J, Duggan M. Severe ulcerative herpes of mouth and eyes following measles. Trans Roy Soc Trop Med Hyg 1979; 73: 66–9.
   PubMed Web of Science ®Google Scholar
• Kipps A, Becker W, Wainwright J, McKenzie D. Fatal disseminated primary Herpesvirus infection in children: epidemiology based on 93 non-neonatal cases. S Afr Med J 1967; 41: 647–51.
   Google Scholar
• Rainot B, Biniaminor M, Schoham C, Rosenthal E. Effect of Levamisole in E-rosetteforming cells in vivo and in vitro in Hodgin's Disease. New Eng J Med 1976; 294: 809–11.
   PubMed Web of Science ®Google Scholar
• Pabst HF, Crawford J. L-tetramisole: Enhancement of human lymphocyte response to antigen. Clin Exp Immunol 1975; 21: 468–73.
   PubMed Web of Science ®Google Scholar
• Wesley A, Coovadia HM, Henderson L. Immunological recovery after measles. Clin Exp Immunol 1978; 32: 544–4.
   Google Scholar
• Coovadia HM, Wesley A, Brain P, Henderson LG, Hallett AF, Vos GH. Immunoparesis and outcome in measles. Lancet 1977; 1: 619–21.
   PubMed Web of Science ®Google Scholar
• Rosenthal M, Trabert U, Muller W. Leucocyte effect of Levamisole. Lancet 1976; 1: 369.
   PubMed Web of Science ®Google Scholar
• Clara R, Germanes J. Levamisole and Agranulocytosis. Lancet 1977; 1: 147–148.
   Google Scholar
• Symoens J, Veys E, Mielants M, Pinals R. Adverse reactions to Levamisole. Cancer Treat Rep 1978; 62: 1721–30.
   PubMedGoogle Scholar